This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Is Oshkosh (OSK) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Oshkosh (OSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Westport (WPRT) Q2 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Westport's (WPRT) second-quarter earnings beat the Zacks Consensus Estimate, while revenues miss the same.
DRVN vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
DRVN vs. GNTX: Which Stock Is the Better Value Option?
Implied Volatility Surging for Gentex (GNTX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Gentex (GNTX) stock based on the movements in the options market lately.
Gentex (GNTX) Q2 Earnings Miss Expectations, Guidance Trimmed
by Zacks Equity Research
Gentex (GNTX) reports lower-than-expected second-quarter results and expects 2024 net sales in the range of $2.40-$2.50 billion, down from the previous estimate of $2.45-$2.55 billion.
Here's What Key Metrics Tell Us About Gentex (GNTX) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Gentex (GNTX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Gentex (GNTX) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of -28.85% and 8.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Oshkosh (OSK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oshkosh (OSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BWA vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
BWA or GNTX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
Bear of the Day: Adient (ADNT)
by Shaun Pruitt
Investors hoping for a rebound in Adient's (ADNT) stock may be disappointed given the downward trend of earnings estimate revisions which still suggests more short-term weakness ahead
BWA vs. GNTX: Which Stock Is the Better Value Option?
by Zacks Equity Research
BWA vs. GNTX: Which Stock Is the Better Value Option?
Lear (LEA) Down 1.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Lear (LEA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Magna (MGA) Stock Down 4% Since Q1 Earnings & Sales Miss
by Zacks Equity Research
Magna (MGA) now expects 2024 revenues in the band of $42.6-$44.2 billion, down from $43.8-$45.4 billion guided earlier.
Autoliv (ALV) Stock Up 7% Since Q1 Earnings & Sales Beat
by Zacks Equity Research
Autoliv (ALV) forecasts full-year 2024 organic sales growth and adjusted operating margin to be around 5% and 10.5%, respectively.
Lear's (LEA) Q1 Earnings Beat, Revenues Match Estimates
by Zacks Equity Research
Lear (LEA) projects its full-year net sales in the band of $24-$24.6 billion, up from $23.5 billion recorded in 2023.
Gentex (GNTX) Q1 Earnings Match Estimates, Increase Y/Y
by Zacks Equity Research
Gentex's (GNTX) first-quarter 2024 earnings match the Zacks Consensus Estimate, while revenues miss the same.
Compared to Estimates, Gentex (GNTX) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Gentex (GNTX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Gentex (GNTX) Q1 Earnings Meet Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Gentex (GNTX) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Gentex (GNTX) Might Surprise This Earnings Season
by Zacks Equity Research
Gentex (GNTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Ahead of Gentex (GNTX) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Gentex (GNTX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Gentex (GNTX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Gentex (GNTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Gentex (GNTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Gentex (GNTX) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.